Literature DB >> 27889621

Identifying non-toxic doses of manganese for manganese-enhanced magnetic resonance imaging to map brain areas activated by operant behavior in trained rats.

Rita Gálosi1, Csaba Szalay2, Mihály Aradi3, Gábor Perlaki4, József Pál5, Roy Steier6, László Lénárd7, Zoltán Karádi7.   

Abstract

Manganese-enhanced magnetic resonance imaging (MEMRI) offers unique advantages such as studying brain activation in freely moving rats, but its usefulness has not been previously evaluated during operant behavior training. Manganese in a form of MnCl2, at a dose of 20mg/kg, was intraperitoneally infused. The administration was repeated and separated by 24h to reach the dose of 40mg/kg or 60mg/kg, respectively. Hepatotoxicity of the MnCl2 was evaluated by determining serum aspartate aminotransferase, alanine aminotransferase, total bilirubin, albumin and protein levels. Neurological examination was also carried out. The animals were tested in visual cue discriminated operant task. Imaging was performed using a 3T clinical MR scanner. T1 values were determined before and after MnCl2 administrations. Manganese-enhanced images of each animal were subtracted from their baseline images to calculate decrease in the T1 value (ΔT1) voxel by voxel. The subtracted T1 maps of trained animals performing visual cue discriminated operant task, and those of naive rats were compared. The dose of 60mg/kg MnCl2 showed hepatotoxic effect, but even these animals did not exhibit neurological symptoms. The dose of 20 and 40mg/kg MnCl2 increased the number of omissions and did not affect the accuracy of performing the visual cue discriminated operant task. Using the accumulated dose of 40mg/kg, voxels with a significant enhanced ΔT1 value were detected in the following brain areas of the visual cue discriminated operant behavior performed animals compared to those in the controls: the visual, somatosensory, motor and premotor cortices, the insula, cingulate, ectorhinal, entorhinal, perirhinal and piriform cortices, hippocampus, amygdala with amygdalohippocampal areas, dorsal striatum, nucleus accumbens core, substantia nigra, and retrorubral field. In conclusion, the MEMRI proved to be a reliable method to accomplish brain activity mapping in correlation with the operant behavior of freely moving rodents. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Magnetic resonance imaging; Manganese; Operant behavior; Rats; Toxicity

Mesh:

Substances:

Year:  2016        PMID: 27889621     DOI: 10.1016/j.mri.2016.11.017

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  5 in total

1.  Manganese-enhanced magnetic resonance imaging depicts brain activity in models of acute and chronic pain: A new window to study experimental spontaneous pain?

Authors:  I M Devonshire; J J Burston; L Xu; A Lillywhite; M J Prior; D J G Watson; C M Greenspon; S J Iwabuchi; D P Auer; V Chapman
Journal:  Neuroimage       Date:  2017-06-17       Impact factor: 6.556

Review 2.  Manganese-Enhanced Magnetic Resonance Imaging: Overview and Central Nervous System Applications With a Focus on Neurodegeneration.

Authors:  Ryan A Cloyd; Shon A Koren; Jose F Abisambra
Journal:  Front Aging Neurosci       Date:  2018-12-13       Impact factor: 5.750

Review 3.  Manganese-Enhanced Magnetic Resonance Imaging: Application in Central Nervous System Diseases.

Authors:  Jun Yang; Qinqing Li
Journal:  Front Neurol       Date:  2020-02-25       Impact factor: 4.003

4.  Brain circuits activated by female sexual behavior evaluated by manganese enhanced magnetic resonance imaging.

Authors:  Alejandro Aguilar-Moreno; Juan Ortiz; Luis Concha; Sarael Alcauter; Raúl G Paredes
Journal:  PLoS One       Date:  2022-08-01       Impact factor: 3.752

5.  A New Tool for In Vivo Study of Astrocyte Connexin 43 in Brain.

Authors:  Marine Droguerre; Tomokazu Tsurugizawa; Adeline Duchêne; Benjamin Portal; Bruno P Guiard; Nicole Déglon; Nathalie Rouach; Michel Hamon; Franck Mouthon; Luisa Ciobanu; Mathieu Charvériat
Journal:  Sci Rep       Date:  2019-12-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.